Navigation Links
New Inspirational Memoir Aims to Support Individuals Battling Depression
Date:9/10/2012

POUGHKEEPSIE, N.Y., Sept. 10, 2012 /PRNewswire/ -- A new book released today chronicles one woman's 30-year battle with major depression and sheds light on how a novel, non-drug therapy saved her life. 3,000 Pulses intimately documents 62-year-old Martha Rhodes' nearly lifelong journey with depression and gives a harrowing yet inspirational account of how it is possible to reclaim your life from the powerful grip of mental illness and attempted suicide.

"I wrote this book to help the millions of people who are suffering from depression realize that they are not alone and there is help out there," said Rhodes. "For me, transcranial magnetic stimulation, or TMS, made all the difference and my wish is that 3,000 Pulses provides others with a beacon of hope that they, too, can find peace."

Rhodes, a former New York advertising executive who seemingly had it all, experienced depressive symptoms as a teenager but wasn't officially diagnosed with major depressive disorder until her late thirties. Rhodes took antidepressant medications for about fifteen years, but over time, the medications stopped working or the side effects became intolerable. Similar to Rhodes, an estimated 4 million people in the U.S. do not benefit from standard treatments for depression, even after repeated treatment attempts. Before Rhodes found relief with TMS, she was at a point in her life where she felt nothing mattered and was ready to give up.

The title 3,000 Pulses is based on the number of highly-focused, magnetic pulses delivered during a typical TMS treatment session to stimulate function in targeted regions of the brain thought to control mood. The book is now available for purchase at www.3000pulses.com.

Rhodes co-authored 3,000 Pulses with Dr. Randy Pardell, MD, DFAPA, Director of Riverview Psychiatric Medicine, who has witnessed firsthand the positive impact of TMS on his patients' lives.

"I have patients who suffered from severe depression for years and experienced remarkable improvements following TMS therapy after little or no response to other antidepressant medications," Pardell said. "I hope that in reading Martha's story, others living with depression will be encouraged to explore new options to treat their symptoms."

About Transcranial Magnetic Stimulation
TMS is a noninvasive, non-systemic therapeutic device that uses short pulses of a magnetic field to stimulate nerve cells in the area of the brain thought to control mood. This pulsed magnetic field may have a positive effect on the brain's neurotransmitters' levels. When used as an antidepressant therapy, TMS produces a clinical benefit without the systemic side effects typical with oral medications and has no adverse effects on cognition as occurs with electroconvulsive therapy. NeuroStar TMS Therapy® is an FDA-cleared non-drug therapy for patients with depression who have not benefitted from one prior antidepressant medication. TMS Therapy is available by prescription only and delivered under the supervision of a psychiatrist. To learn more visit: www.neurostar.com.

About Depression
Depression is a serious illness that affects about 20 million Americans annually. People with depression may experience a range of physically and emotionally debilitating symptoms, including anxiousness, sadness, irritability, fatigue, changes in sleep patterns, loss of interest in previously enjoyable activities and digestive problems. Each year in the U.S., more than 30,000 people die by suicide, 60 percent of whom suffer from depression.


'/>"/>
SOURCE TMS
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharma Industry Stretching Every Dollar: New Study Finds Rise in Outsourcing of Key Support Functions
2. FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis
3. Novation Supports New Development in the U.S. Biosimilar Pharmaceuticals Market
4. Henry Schein Cares Disaster Relief Hotline is Active and Ready to Support Customers Affected by Hurricane Isaac
5. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Minneapolis-St. Paul Parents to Vaccinate Preteens and Teens
6. Patient Advocate Foundation Receives Significant Support to Aid Non-Squamous Non-Small Cell Lung Cancer Patients through the Co-Pay Relief Program
7. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
8. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Nashville Parents to Vaccinate Preteens and Teens
9. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
10. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges St. Louis Parents to Vaccinate Preteens and Teens
11. USPIs Physician Strategy Group Partners with Provista to Support their Affiliated Physician Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 2017 Stock-Callers.com today evaluates the following ... ), Novo Nordisk A/S (NYSE: NVO ), Sucampo ... Holdings Inc. (NASDAQ: PTX ). These stocks belong ... th , 2017, finishing near its session lows. As per ... 0.7%, while shares of health care companies in the S&P ...
(Date:1/20/2017)... January 20, 2017 Avillion LLP, a co-developer ... Mark Weinberg , MD MBA as Chief Medical Officer. Dr ... USA . ... Dr Weinberg has spent more than 17 years as a ... companies to micro-cap biotech. Over the course of his career, he ...
(Date:1/19/2017)... Jan. 19, 2017 The U.S. Food and Drug ... Idiopathic Constipation (CIC) in adult patients. "No ... disorders," said Julie Beitz , M.D., director of the ... Drug Evaluation and Research. "With the availability of new therapies, ... for their condition." ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... ... “The Inn at the Mill”: a story of love and redemption, hope and uncertainty ... and content. , “The Inn at the Mill” is the creation of published author, ... and is now living in Berks County on Crow Hill. The inn, the ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... programs and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in teaching communities ... These resources have been developed for use by nutrition educators and influencers ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Some Infallible Characteristics of Christ”: a ... Characteristics of Christ” is the creation of published author, Rev. Dr. Robert W. Thomas, ... thirteen years, a preacher for over nineteen, a pastor for over fifteen years. He ...
(Date:1/22/2017)... ... January 22, 2017 , ... Phytocéane invites clients to take an ... of the world with ZANZIBAR MILKY CREAM. Inspired by the beauty of Zanzibar, a ... Coconut Oil and moisturizing vegetal coral to create this gentle, velvety body cream to ...
(Date:1/22/2017)... ... 22, 2017 , ... "Photo Cloud allows FCPX users to add favorited photos ... complete ease," said Christina Austin - CEO of Pixel Film Studios. , To ... timeline. Presets include scenes with one, three, four or five focus points. There ...
Breaking Medicine News(10 mins):